The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia
Greetje J. de Grooth(Radboud University Nijmegen), Jan Albert Kuivenhoven(University Medical Center Groningen), Aeilko H. Zwinderman(Amsterdam Neuroscience), Sanne van Wissen(Academic Medical Center), John J.P. Kastelein(QRx Pharma (United States)), Anton F. H. Stalenhoef(Translational Therapeutics (United States)), Jean‐Charles Fruchart(Institut Pasteur de Lille), Anke H.E.M. Klerkx(Amsterdam UMC Location University of Amsterdam), Tineke J. Smilde(Champalimaud Foundation)
Cited by 84
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k